Understanding Late-Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial Design
Arthritis Rheumatol
.
2025 Apr;77(4):380-382.
doi: 10.1002/art.43053.
Epub 2024 Dec 1.
Author
Elizabeth R Volkmann
1
Affiliation
1
David Geffen School of Medicine, University of California, Los Angeles.
PMID:
39491472
PMCID:
PMC11945440
DOI:
10.1002/art.43053
No abstract available
Publication types
Editorial
Grants and funding
K23 HL150237/HL/NHLBI NIH HHS/United States
K23 HL150237/HL/NHLBI NIH HHS/United States